Concepedia

LP14 : A phase 3, randomised, open-label study to evaluate the efficacy and safety of 8 and 12 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-naïve and -experienced patients with chronic HCV genotype 1 infection without cirrhosis: Optimist-1

Paul Y. Kwo, Norman Gitlin, Ronald Nahass, David Bernstein, Sergio Rojter, E. Schiff, Mitchell Davis, Peter Ruane, Ziad Younes, Ronald Kalmeijer,

Journal of Hepatology · 2015 · 67 citations · 0 references

Concepts

PharmacyInfectious DiseasesPharmacotherapyHepatic PharmacotherapyHepatitis PharmacotherapyVirologyAntiviral PharmacologyAntiviral TherapyCirrhosisInterferon-based TherapyViral HepatitisViral Hepatitis TreatmentAntiviral Therapy In CirrhosisHepatitis A Virus ManagementHepatitis C Virus ManagementOpen-label TrialsViral Hepatitis-related Cirrhosis